20 Years of Proven Impact: Plus Antibacterial Sutures at Surgical Site Infections | J&J MedTech

Подробнее о видео

Join infection prevention experts Charles Edmiston, Maureen Spencer, and Peter Graves, as they discuss the evidence and impact of Plus Antibacterial Sutures on Surgical site infections (SSI) over the last 20 years. SSIs are associated with significant patient morbidity and mortality. Efforts to reduce the risk of SSIs require knowledge of the mechanistic factors responsible for the etiology of these severe healthcare-associated infections (HAI). Therefore, the development of a successful patient-centric pathway to improving surgical outcomes requires matching comorbid risk with effective evidence-based interventional strategies. The cornerstone for this improvement in clinical outcome is the surgical care bundle which is not a static but rather a dynamic process that is subject to change since evidence-based medicine is an evolutionary process. More about wound closure here►

00:00 Introduction
01:21 Reducing the Risk of Surgical Site Infections with Charles Edmiston Jr, PhD
03:29 Validation of Antimicrobial Wound Closure Technology
05:47 Microscopic Perspective of Deep Incisional Biofilm Mediated Surgical Site Infection
15:58 How to Select Evidence Based (EB) - Surgical Care Bundle
19:38 Frequently asked Q&A

More videos on Clinical Innovation ►

Subscribe to J&J MedTech and stay tuned for the latest innovation in surgical procedures and medical devices:

Follow us on Twitter at
Follow us on LinkedIn at

To view additional on-demand online learning resources, visit
Follow J&J Institute on LinkedIn at
Follow J&J Institute on Twitter at

This video showcases two decades of demonstrated effectiveness of Plus Antibacterial Sutures.
#JnJMedTech #WoundClosure #SurgicalSiteInfection
244000-230324